Model N Announces State of Revenue Webinars for Life Sciences and High-Tech Industries
Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, today announced its upcoming State of Revenue webinars on February 7 at 11 a.m. ET and 1 p.m. ET. The live webinars will coincide with the release of the company's fifth annual State of Revenue Report.
What:
Be the first to hear from Model N's industry experts as they present key insights from the 2023 State of Revenue Report. The survey covers insights from executives responsible for optimizing revenue and ensuring compliance at large high-tech, semiconductor manufacturing, pharmaceutical and medical technology companies. Speakers will discuss:
How revenue management teams are evolving to capitalize on new opportunities and overcome the macroeconomic trends that make revenue optimization so difficult.
Ways that life sciences and high-tech organizations can leverage technology to support revenue management, channel, and compliance activities.
Who:
Jesse Mendelsohn, SVP of Center of Excellence at Model N
Gloria Kee, Vice President of Product Management at Model N
Kyle Forcier, Sr. Director of Product Marketing at Model N
Chris Shrope, Associate Director of Product Marketing at Model N
Adam Steele, Marketing Director at Model N
When:
February 7, 2023, 11 a.m. ET (Life Sciences) and 1 p.m. ET (High Tech)
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. Our intelligent platform powers your digital transformation with integrated technology, data, analytics, and expert services that deliver deep insight and control.
Our integrated cloud solution is proven to automate pricing, incentive and contract decisions to scale business profitably and grow revenue. Model N is trusted across more than 120 countries by the world's leading pharmaceutical, medical technology, semiconductor, and high-tech companies, including Johnson & Johnson, AstraZeneca, Stryker, Seagate Technology, Broadcom, and Microchip Technology. For more information, visit www.modeln.com.
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period.
The...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...